IDH1 and acute myeloid leukemia: DNMT3A mutations frequently co-occur with NPM1, FLT3, and IDH1 (76), and overall approximately 20% of patients with AML (69, 71) and 8% of patients with MDS (70) carry a mutation in this factor.